The increase in activating EGFR mutation in plasma is an early biomarker to monitor response to osimertinib: a case report
Pre-publication versions of this article are available by contacting email@example.com.
|5 Apr 2018||Submitted||Original manuscript|
|26 Jul 2018||Reviewed||Reviewer Report - Kadoaki Ohashi|
|24 Sep 2018||Reviewed||Reviewer Report - Reviewer 2|
|19 Oct 2018||Author responded||Author comments - Eleonora Rofi|
|Resubmission - Version 2|
|19 Oct 2018||Submitted||Manuscript version 2|
|6 Nov 2018||Reviewed||Reviewer Report - Kadoaki Ohashi|
|6 Mar 2019||Author responded||Author comments - Marzia Del Re|
|Resubmission - Version 3|
|6 Mar 2019||Submitted||Manuscript version 3|
|9 Apr 2019||Author responded||Author comments - Marzia Del Re|
|Resubmission - Version 4|
|9 Apr 2019||Submitted||Manuscript version 4|
|12 Apr 2019||Editorially accepted|
|30 Apr 2019||Article published||10.1186/s12885-019-5604-6|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting firstname.lastname@example.org.
You can find further information about the peer review system here.